The growth of animal cells is controlled by external factors at a few hours prior to DNA synthesis. Cancer cells are deranged in this control. The proposed work is designed to continue our studies on the biochemical events that occur during this control period, and their derangements in cancer cells. Studies on cell cycle progression led to our proposal that a key component is a rather short-lived protein (in normal cells) that is stabilized in various cancer forming cells. Such a protein was identified using 2D gels. Antibody will be prepared against this protein, to facilitate its further study in the cell (location, timing of synthesis) and in extracts (properties, basis for changed stability in cancer cells). Microinjection of the protein into mammalian cells or Xenopus oocytes will be done to study its function in turning on DNA synthesis. The initiation of DNA synthesis involves production of enzymes of the DNA pathway, and their assembly in the nucleus, into a multienzyme complex. These enzymes, and also the corresponding mRNAs, will be studied as to control of their formation through cloned probes. Somatomedin C appears to be required for the final steps. Roles of somatomedin C and of the labile protein in production of the enzymes and of the multienzyme complex will be studied. A longer term goal will be to clone the gene for the labile protein, from cancer and normal cells to investigate its function and sequence, and to see whether it has oncogene activity, by transfection.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM024571-08
Application #
3272400
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1978-05-01
Project End
1989-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
8
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
Voulgaris, J; Pokholok, D; Holmes, W M et al. (2000) The feedback response of Escherichia coli rRNA synthesis is not identical to the mechanism of growth rate-dependent control. J Bacteriol 182:536-9
Molnar, G M; Crozat, A; Kraeft, S K et al. (1997) Association of the mammalian helicase MAH with the pre-mRNA splicing complex. Proc Natl Acad Sci U S A 94:7831-6
Alpan, R S; Pardee, A B (1996) p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ 7:893-901
Alpan, R S; Zhang, M; Pardee, A B (1996) Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line. Cancer Res 56:4358-61
Dou, Q P; Pardee, A B (1996) Transcriptional activation of thymidine kinase, a marker for cell cycle control. Prog Nucleic Acid Res Mol Biol 53:197-217
Alpan, R S; Sparvero, S; Pardee, A B (1996) Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display method. Mol Med 2:469-78
Dou, Q P; An, B; Yu, C (1995) Activation of cyclin E-dependent kinase by DNA-damage signals during apoptosis. Biochem Biophys Res Commun 214:771-80
Molnar, G; O'Leary, N; Pardee, A B et al. (1995) Quantification of DNA-protein interaction by UV crosslinking. Nucleic Acids Res 23:3318-26
Keyomarsi, K; O'Leary, N; Molnar, G et al. (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-5
Pardee, A B (1994) Growth dysregulation in cancer cells. Adv Cancer Res 65:213-28

Showing the most recent 10 out of 47 publications